Published
Riyaz Shah, BSc(Hons), MBBS, FRCP, PhD, Kent Oncology Centre, UK, discusses the role of immunotherapy for the treatment of patient with mesothelioma. The Phase III CHECKMATE-743 (NCT02899299) study highlighting the benefit of immunotherapy in the first-line setting. This interview took place at the BTOG 2022 Summer Meeting congress in London.
- Category
- Health
Be the first to comment
-
39:42
Idiopathic pulmonary fibrosis || Sarcoidosis || Pneumoconioses || Mesothelioma
-
01:49
1L treatment in mesothelioma: optimizing treatments for individual patients
-
1:09:47
How to Select the Right Immunotherapy for First-Line Treatment of Advanced NSCLC
-
04:06
Immunotherapy for Head and Neck Cancer Treatment
-
01:15
NCI Minute: CAR-T Cell Immunotherapy for Cancer Treatment
-
03:51
CELIAC DISEASE can be treated with IMMUNOTHERAPY (Novel Treatment)
-
1:38:34
An Algorithmic Approach to Immunotherapy-Based Treatment in Hepatobiliary Carcinomas
-
05:43
An innovative approach to cancer treatment – Targeted therapy and Immunotherapy
-
49:11
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans in Resectable NSCLC
-
05:14
New Immunotherapy Treatment for Canine Cancer
-
03:19
Jowar Khichdi Recipe | Healthy & Yummy | Gluten Free Weight Loss Millet Recipes | Culinary Aromas
-
08:07
৭ দিনে যৌন ক্ষমতা বাড়ানোর কুরআনী চিকিৎসা/ Treatment of metal corrosion disease in Bangla
-
00:12
Healthy Lifestyle
